The Screening to Brief Intervention (S2BI) tool was designed to identify substance use disorders in adolescents. We report the S2BI's sensitivity and specificity for identifying alcohol and cannabis use disorders (AUD and CUD) in adolescents presenting for primary care.
Methods
Participants aged 14–18 (N = 517) completed an electronic survey, consisting of the S2BI, the Composite International Diagnostic Interview (CIDI), and anxiety and depression screens. We calculated sensitivity, specificity, and positive and negative predictive value (PPV, NPV) of the S2BI compared to the CIDI criterion standard, using past year “monthly” and “weekly or more” consumption of alcohol or marijuana as a threshold for AUD or CUD.
Results
Current AUD and CUD were present in 2.9% and 8.3% of the sample, respectively and severe AUD and CUD were present in 0.8% and 3.9%. The S2BI had 53.3% sensitivity and 94.2% specificity for identifying any AUD (PPV = 21.6%; NPV = 98.5%), and 81.4% sensitivity and 92.0% specificity for identifying any CUD (PPV = 47.9%; NPV = 98.2%). The same threshold had 100% sensitivity and 93.6% specificity for identifying moderate/severe AUD, and 90.0% sensitivity and 89.0% specificity for identifying moderate/severe CUD.
Conclusions
S2BI had excellent sensitivity and specificity for identifying moderate and severe AUD and CUD. Sensitivity decreased when mild AUD and CUD were included.
National Institute on Alcohol Abuse and Alcoholism (US). AlcoholScreening and Brief Intervention for Youth: A Practitioner's Guide. National Institute on Alcohol Abuse and Alcoholism, US Department of Health and Human Services, National Institutes of Health; 2011. https://pubs.niaaa.nih.gov/publications/Practitioner/YouthGuide/YouthGuide.pdf. Accessed July 20, 2018.
2.
Substance Abuse and Mental Health Services Administration. Systems-Level Implementation of Screening, Brief Intervention, and Referral to Treatment. Technical Assistance Publication (TAP) Series 33. HHS Publication No. (SMA) 13-4741. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013. http://www.integration.samhsa.gov/sbirt/tap33.pdf. Accessed April 7, 2015.
AAP Committee on Substance Use and Prevention.Screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e20161211.
5.
WiskLE, WeitzmanER.Substance use patterns through early adulthood: results for youth with and without chronic conditions. Am J Prev Med. 2016;51(1):33–45.
6.
Committee on Substance Abuse. Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics. 2011;128(5):e1330–e1340.
7.
McCartyCA, LevyS, HarrisSK.Alcohol use screening and behavioral counseling with adolescents in primary care: a call to action. JAMA Pediatr. 2019;173(1):12–14.
8.
RehmJ, BaliunasD, BorgesGLG, . The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105(5):817–843.
9.
WeitzmanER, ZiemnikRE, HuangQ, LevyS.Alcohol and marijuana use and treatment nonadherence among medically vulnerable youth. Pediatrics. 2015;136(3):450–457.
10.
HarstadE, LevyS.Committe on Substance Abuse. Attention-deficit/hyperactivity disorder and substance abuse. Pediatrics. 2014;134(1):e293-301–e301.
11.
ShrierLA, HarrisSK, KurlandM, KnightJR.Substance use problems and associated psychiatric symptoms among adolescents in primary care. Pediatrics. 2003;111(6 Pt 1):e699–e705.
12.
ElkindAH.Drug abuse and headache. Med Clin North Am. 1991;75(3):717–732.
13.
DimitrijevićI, KalezićN, RistićJ, BojovićO, DimitrijevićN.Digestive system damage caused by substance abuse. Acta Chir Iugosl. 2008;55(3):133–138.
14.
WeitzmanER, MaganeKM, WiskLE, AllarioJ, HarstadE, LevyS.Alcohol use and alcohol-interactive medications among medically vulnerable youth. Pediatrics. 2018;142(4):e20174026.
KnightJR, ShrierLA, BravenderTD, FarrellM, Vander BiltJ, ShafferHJ.A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med. 1999;153(6):591–596.
18.
DhallaS, ZumboBD, PooleG, PoolemG.A review of the psychometric properties of the CRAFFT instrument: 1999–2010. Curr Drug Abuse Rev. 2011;4(1):57–64.
19.
SpiritoA, BrombergJR, CasperTC, . Reliability and validity of a two-question alcohol screen in the pediatric emergency department. Pediatrics. 2016;138(6):e20160691–e20160691.
20.
DamicoEJ, ParastL, MeredithLS, EwingBA, ShadelWG, SteinBD.Screening in primary care: what is the best way to identify at-risk youth for substance use?Pediatrics. 2016;138(6):e20161717–e20161717.
21.
LevyS, DedeogluF, GaffinJM, . A screening tool for assessing alcohol use risk among medically vulnerable youth. Vrana KE, ed. PLoS One. 2016;11(5):e0156240.
22.
LevyS, WeissR, SherrittL, . An electronic screen for triaging adolescent substance use by risk levels. JAMA Pediatr. 2014;168(9):822–828.
23.
KellySM, GryczynskiJ, MitchellSG, KirkA, O'GradyKE, SchwartzRP.Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use. Pediatrics. 2014;133(5):819–826.
24.
American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
25.
PittsS, ShrierLA.Substance abuse screening and brief intervention for adolescents in primary care. Pediatr Ann. 2014;43(10):e248–e252.
CottlerLB.Composite International Diagnostic Interview–Substance Abuse Module (CIDI-SAM). St. Louis, MO: Department of Psychiatry, Washington University School of Medicine; 2000.
28.
ArrollB, Goodyear-SmithF, CrengleS, . Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4):348–353.
29.
SkapinakisP.The 2-item generalized anxiety disorder scale had high sensitivity and specificity for detecting GAD in primary care. Evid Based Med. 2007;12(5):149.
30.
GryczynskiJ, MitchellSG, SchwartzRP, . Disclosure of adolescent substance use in primary care: comparison of routine clinical screening and anonymous research interviews. J Adolesc Heal. 2019;64(4):541–543.
31.
DiFranzaJR, RichmondJB.Let the children be heard: lessons from studies of the early onset of tobacco addiction. Pediatrics. 2008;121(3):623–624.
32.
SterlingS, Kline-SimonAH, WibbelsmanC, WongA, WeisnerC.Screening for adolescent alcohol and drug use in pediatric health-care settings: predictors and implications for practice and policy. Addict Sci Clin Pract. 2012;7(1):13.
33.
LevyS, ZiemnikRE, HarrisSK, . Screening adolescents for alcohol use: tracking practice trends of Massachusetts pediatricians. J Addict Med. 2017;11(6):427–434.
34.
BarryKL, BlowFC, WillenbringML, McCormickR, BrockmannLM, VisnicS.Use of alcohol screening and brief interventions in primary care settings: implementation and barriers. Subst Abus. 2004;25(1):27–36.
35.
LevyS, WiseblattA, StrausJ, StrotherH, FluetC, HarrisS.Adolescent SBIRT practices among pediatricians in Massachusetts. J Addict Med. 2019;14(2):145–149.
36.
WilsonCR, SherrittL, GatesE, KnightJR.Are clinical impressions of adolescent substance use accurate?. Pediatrics. 2004;114(5):e536–e540.
37.
RobinsLN, WingJ, WittchenHU, . The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45(12):1069–1077.
38.
CottlerLB, RobinsLN, HelzerJE.The reliability of the CIDI-SAM: a comprehensive substance abuse interview. Br J Addict. 1989;84(7):801–814.
